Clik here to view.
Accuray wins Japanese regulatory nod for Radixact platform
Accuray (NSDQ:ARAY) said today it won approval from the Japanese Ministry of Health, Labor and Welfare for its Radixact treatment delivery platform designed for image-guided radiotherapy treatments...
View ArticleClik here to view.
Nu-Med Plus inks $700k stock purchase deal
Nu-Med Plus said today it inked a stock agreement which will fund the company through Feb. of next year. The Salt Lake City, Utah-based company completed a stock purchase agreement with Smith Corporate...
View ArticleClik here to view.
Smith & Nephew misses the mark with 2016 results
Smith & Nephew (NYSE:SNN) today posted 2016 numbers that missed the consensus forecast, sending share prices down today in London and New York despite a net profit gain of more than 91%. Europe’s...
View ArticleClik here to view.
New Indian medical device regulations for 2017
By Stewart Eisenhart, Emergo Group The Indian government is planning a significant overhaul of its system for regulating medical devices and IVDs. Emergo is still analyzing the new Medical Device Rules...
View ArticleClik here to view.
New imaging agent detects metastatic prostate cancer cells
Ga-68-BBN PET/CT of a 64-year-old man newly diagnosed with prostate cancer by biopsy. Multiple bone metastasis lesions (arrows) were detected. [Image from Jingjing Zhang, Peking Union Medical College,...
View ArticleClik here to view.
Maxon Motor spending $30 million on new Innovation Center
Maxon Motor is investing roughly $30 million (CHF 30 million) to add a new Innovation Center to its headquarters in Switzerland. The expansion construction of the new Innovation Center is set to begin...
View ArticleClik here to view.
UPDATE: Medtronic wins Health Canada license for drug-coated balloon, touts...
Medtronic (NYSE:MDT) touted 1 year data from the In.Pact SFA Japan trial of its drug-coated balloon compared to plain balloon angioplasty. The company also said today it won regulatory approval in...
View ArticleClik here to view.
Intuitive Surgical warns of risks on Obamacare repeal, NAFTA withdrawal, Brexit
Intuitive Surgical (NSDQ:ISRG) last week warned of the risks posed to its business by the geopolitical shifts of the past year, including the likely repeal of Obamacare, the U.S.’s threatened...
View ArticleClik here to view.
Gore must cough up fees to cover pursuit of sanctions in stent graft spat...
A federal judge in Delaware yesterday ordered W.L. Gore & Assoc. to cough up some of the legal fees C.R. Bard (NYSE:BCR) incurred in defending itself against Gore’s bid for sanctions against Bard’s...
View ArticleClik here to view.
Acorda’s inhaled Parkinson’s drug meets primary endpoint in Phase III trial
Acorda Therapeutics (NSDQ:ACOR) said today that the phase III clinical trial evaluating its inhaled formulation of Parkinson’s drug levodopa met its primary endpoint. The drug was studied as a therapy...
View ArticleClik here to view.
EnteroMedics touts long-term data for vBloc therapy
EnteroMedics (NSDQ:ETRM) said today that 3-year data from a study of its vBloc neurometabolic therapy in obese patients with type II diabetes were published in the Journal of Diabetes and Obesity. The...
View ArticleClik here to view.
Medacta International acquires Vivamed
Medacta International has announced its acquisition of the Austrian distributor Vivamed. The acquisition went into effect on Feb. 1. Medacta, a privately held and family-owned global designer of joint...
View ArticleClik here to view.
FDA warns on over-inflation, pancreatitis risks with ReShape, Apollo...
The FDA today warned of potential risks associated with fluid-filled intragastric balloons, produced by ReShape Medical and Apollo Endosurgery, which are used to treat obesity. The federal watchdog...
View ArticleClik here to view.
Helius Medical touts data from multiple sclerosis pilot study of PONS system
Helius Medical Technologies said today that clinical data from a multiple sclerosis pilot study of its portable neuromodulation stimulator was published in the Multiple Sclerosis Journal: Experimental,...
View ArticleClik here to view.
Abbott initiates recall of StarClose SE vascular closure system
Updated to reflect that there were 38 lot numbers identified in the recall, not part numbers. Abbott (NYSE:ABT) said yesterday it initiated an urgent recall of its StarClose SE vascular closure system...
View ArticleClik here to view.
Researchers develop bioink for 3D-printed pills
Researchers at the University of California Los Angeles have developed a viable bioink made out of hyaluronic acid for 3D-printed pills. In this study, researchers used an inket technique to 3D print...
View ArticleClik here to view.
pSivida shares gain on Q2 earnings
Shares in pSivida (NSDQ:PSDV) rose yesterday after the medical device maker met expectations on Wall Street with its fiscal 2nd quarter results. The Watertown, Mass.-based company pared its losses to...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for February 9, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
First patients treated in pivotal trial for Theraclion’s Echopulse device
Theraclion (EPA:ALTHE) said today that the 1st patients were treated in the U.S. pivotal clinical trial evaluating the safety and efficacy of the company’s Echopulse echotherapy device as a...
View ArticleClik here to view.
Hill-Rom plans $300m private offering to fund Mortara acquisition
Hill-Rom (NYSE:HRC) today announced a $300 million private placement with net proceeds to fund its acquisition of Mortara Instrument. The Chicago-based company said it will be selling senior unsecured...
View Article
